GLP-1 Receptor Agonists Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: GC5F25B11BAFEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of GLP-1 Receptor Agonists in Global, including the following market information:

Global GLP-1 Receptor Agonists Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global GLP-1 Receptor Agonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Exenatide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of GLP-1 Receptor Agonists include GSK, Novo Nordisk, Lily, Haosoh, Sanofi and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GLP-1 Receptor Agonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global GLP-1 Receptor Agonists Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global GLP-1 Receptor Agonists Market Segment Percentages, by Type, 2021 (%)

• Exenatide
• Liraglutide
• Lixisenatide
• Albiglutide
• Others

Global GLP-1 Receptor Agonists Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global GLP-1 Receptor Agonists Market Segment Percentages, by Application, 2021 (%)

• Solid Tumors
• Blood-related Tumors

Global GLP-1 Receptor Agonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global GLP-1 Receptor Agonists Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies GLP-1 Receptor Agonists revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies GLP-1 Receptor Agonists revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Novo Nordisk
• Lily
• Haosoh
• Sanofi
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 GLP-1 Receptor Agonists Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global GLP-1 Receptor Agonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLP-1 RECEPTOR AGONISTS OVERALL MARKET SIZE

2.1 Global GLP-1 Receptor Agonists Market Size: 2021 VS 2028
2.2 Global GLP-1 Receptor Agonists Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top GLP-1 Receptor Agonists Players in Global Market
3.2 Top Global GLP-1 Receptor Agonists Companies Ranked by Revenue
3.3 Global GLP-1 Receptor Agonists Revenue by Companies
3.4 Top 3 and Top 5 GLP-1 Receptor Agonists Companies in Global Market, by Revenue in 2021
3.5 Global Companies GLP-1 Receptor Agonists Product Type
3.6 Tier 1, Tier 2 and Tier 3 GLP-1 Receptor Agonists Players in Global Market
  3.6.1 List of Global Tier 1 GLP-1 Receptor Agonists Companies
  3.6.2 List of Global Tier 2 and Tier 3 GLP-1 Receptor Agonists Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global GLP-1 Receptor Agonists Market Size Markets, 2021 & 2028
  4.1.2 Exenatide
  4.1.3 Liraglutide
  4.1.4 Lixisenatide
  4.1.5 Albiglutide
  4.1.6 Others
4.2 By Type - Global GLP-1 Receptor Agonists Revenue & Forecasts
  4.2.1 By Type - Global GLP-1 Receptor Agonists Revenue, 2017-2022
  4.2.2 By Type - Global GLP-1 Receptor Agonists Revenue, 2023-2028
  4.2.3 By Type - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global GLP-1 Receptor Agonists Market Size, 2021 & 2028
  5.1.2 Solid Tumors
  5.1.3 Blood-related Tumors
5.2 By Application - Global GLP-1 Receptor Agonists Revenue & Forecasts
  5.2.1 By Application - Global GLP-1 Receptor Agonists Revenue, 2017-2022
  5.2.2 By Application - Global GLP-1 Receptor Agonists Revenue, 2023-2028
  5.2.3 By Application - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global GLP-1 Receptor Agonists Market Size, 2021 & 2028
6.2 By Region - Global GLP-1 Receptor Agonists Revenue & Forecasts
  6.2.1 By Region - Global GLP-1 Receptor Agonists Revenue, 2017-2022
  6.2.2 By Region - Global GLP-1 Receptor Agonists Revenue, 2023-2028
  6.2.3 By Region - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America GLP-1 Receptor Agonists Revenue, 2017-2028
  6.3.2 US GLP-1 Receptor Agonists Market Size, 2017-2028
  6.3.3 Canada GLP-1 Receptor Agonists Market Size, 2017-2028
  6.3.4 Mexico GLP-1 Receptor Agonists Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe GLP-1 Receptor Agonists Revenue, 2017-2028
  6.4.2 Germany GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.3 France GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.4 U.K. GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.5 Italy GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.6 Russia GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.7 Nordic Countries GLP-1 Receptor Agonists Market Size, 2017-2028
  6.4.8 Benelux GLP-1 Receptor Agonists Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia GLP-1 Receptor Agonists Revenue, 2017-2028
  6.5.2 China GLP-1 Receptor Agonists Market Size, 2017-2028
  6.5.3 Japan GLP-1 Receptor Agonists Market Size, 2017-2028
  6.5.4 South Korea GLP-1 Receptor Agonists Market Size, 2017-2028
  6.5.5 Southeast Asia GLP-1 Receptor Agonists Market Size, 2017-2028
  6.5.6 India GLP-1 Receptor Agonists Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America GLP-1 Receptor Agonists Revenue, 2017-2028
  6.6.2 Brazil GLP-1 Receptor Agonists Market Size, 2017-2028
  6.6.3 Argentina GLP-1 Receptor Agonists Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa GLP-1 Receptor Agonists Revenue, 2017-2028
  6.7.2 Turkey GLP-1 Receptor Agonists Market Size, 2017-2028
  6.7.3 Israel GLP-1 Receptor Agonists Market Size, 2017-2028
  6.7.4 Saudi Arabia GLP-1 Receptor Agonists Market Size, 2017-2028
  6.7.5 UAE GLP-1 Receptor Agonists Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK GLP-1 Receptor Agonists Major Product Offerings
  7.1.4 GSK GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk GLP-1 Receptor Agonists Major Product Offerings
  7.2.4 Novo Nordisk GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Lily
  7.3.1 Lily Corporate Summary
  7.3.2 Lily Business Overview
  7.3.3 Lily GLP-1 Receptor Agonists Major Product Offerings
  7.3.4 Lily GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.3.5 Lily Key News
7.4 Haosoh
  7.4.1 Haosoh Corporate Summary
  7.4.2 Haosoh Business Overview
  7.4.3 Haosoh GLP-1 Receptor Agonists Major Product Offerings
  7.4.4 Haosoh GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.4.5 Haosoh Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi GLP-1 Receptor Agonists Major Product Offerings
  7.5.4 Sanofi GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca GLP-1 Receptor Agonists Major Product Offerings
  7.6.4 AstraZeneca GLP-1 Receptor Agonists Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. GLP-1 Receptor Agonists Market Opportunities & Trends in Global Market
Table 2. GLP-1 Receptor Agonists Market Drivers in Global Market
Table 3. GLP-1 Receptor Agonists Market Restraints in Global Market
Table 4. Key Players of GLP-1 Receptor Agonists in Global Market
Table 5. Top GLP-1 Receptor Agonists Players in Global Market, Ranking by Revenue (2021)
Table 6. Global GLP-1 Receptor Agonists Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global GLP-1 Receptor Agonists Revenue Share by Companies, 2017-2022
Table 8. Global Companies GLP-1 Receptor Agonists Product Type
Table 9. List of Global Tier 1 GLP-1 Receptor Agonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GLP-1 Receptor Agonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global GLP-1 Receptor Agonists Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - GLP-1 Receptor Agonists Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - GLP-1 Receptor Agonists Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global GLP-1 Receptor Agonists Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - GLP-1 Receptor Agonists Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - GLP-1 Receptor Agonists Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global GLP-1 Receptor Agonists Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global GLP-1 Receptor Agonists Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global GLP-1 Receptor Agonists Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America GLP-1 Receptor Agonists Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe GLP-1 Receptor Agonists Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia GLP-1 Receptor Agonists Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America GLP-1 Receptor Agonists Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa GLP-1 Receptor Agonists Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK GLP-1 Receptor Agonists Product Offerings
Table 32. GSK GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk GLP-1 Receptor Agonists Product Offerings
Table 35. Novo Nordisk GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)
Table 36. Lily Corporate Summary
Table 37. Lily GLP-1 Receptor Agonists Product Offerings
Table 38. Lily GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)
Table 39. Haosoh Corporate Summary
Table 40. Haosoh GLP-1 Receptor Agonists Product Offerings
Table 41. Haosoh GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi GLP-1 Receptor Agonists Product Offerings
Table 44. Sanofi GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca GLP-1 Receptor Agonists Product Offerings
Table 47. AstraZeneca GLP-1 Receptor Agonists Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. GLP-1 Receptor Agonists Segment by Type in 2021
Figure 2. GLP-1 Receptor Agonists Segment by Application in 2021
Figure 3. Global GLP-1 Receptor Agonists Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global GLP-1 Receptor Agonists Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global GLP-1 Receptor Agonists Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by GLP-1 Receptor Agonists Revenue in 2021
Figure 8. By Type - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 9. By Application - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 10. By Region - Global GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 11. By Country - North America GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 12. US GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 13. Canada GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 16. Germany GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 17. France GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 19. Italy GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 20. Russia GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 24. China GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 25. Japan GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 28. India GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 30. Brazil GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa GLP-1 Receptor Agonists Revenue Market Share, 2017-2028
Figure 33. Turkey GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 34. Israel GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 36. UAE GLP-1 Receptor Agonists Revenue, (US$, Mn), 2017-2028
Figure 37. GSK GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lily GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Haosoh GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca GLP-1 Receptor Agonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)